Category Archives: Healthcare Information

Parenteral Drug Association’s “ICH Q7 GMP for APIs” online training module is now endorsed by ICH

BERLIN, 22-Nov-2019 — /EPR HEALTHCARE NEWS/ — The Parenteral Drug Association (PDA) is proud to announce that its “ICH Q7 GMP for APIs” online training module is now endorsed by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use as an “ICH Recognised Training Programme.”

The training module received the distinction after PDA demonstrated to ICH that it meets the twelve eligibility criteria for the program. Among these are its mission to serve as a neutral convening platform to engage expert stakeholders from industry, academia, advocacy groups, non-profits, and/or regulatory agencies on critical regulatory topics, and its promotion of regulatory convergence to accelerate innovation and improve healthcare globally.

The free “ICH Q7 GMP for APIs” training module introduces and improves understanding of the ICH quality guideline, Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients. The webinar is intended for pharmaceutical professionals working with APIs. More information on the webinar is available here: https://www.pda.org/global-event-calendar/ich-q7-gmp-for-apis.

SOURCE: EuropaWire

###

First Rhenium-SCT® (Skin Cancer Therapy) treatment in Germany done by Dr. Lutz-Hendrik Holle

HANAU, Germany, 4-Oct-2019 — /EPR HEALTHCARE NEWS/ — OncoBeta®, a Medical Device Company specialized in innovative epidermal radioisotope therapies for Non-Melanocytic Skin Cancers (NMSCs), announced today, that Dr. Lutz-Hendrik Holle, Medical Director of the interregional professional association for nuclear medicine in Hanau, has accomplished the first Rhenium-SCT® (Skin Cancer Therapy) treatment in Germany. This state-of-the-art technology of local radionuclide therapy offers a painless and non-invasive treatment option for patients with basal cell carcinoma and squamous cell carcinoma (BCC and SCC) and the interregional professional association for nuclear medicine Hanau is the first center in Germany that offers the Rhenium-SCT®.

With approximately 50.000 outpatient examinations annually, the interregional professional association for nuclear medicine Hanau is one of the biggest nuclear medicine service providers in Hesse. The offered services include a variety of different modern treatment and diagnostic methods. The key argument for the expansion of the spectrum was that the Rhenium-SCT® is a new, painless and highly efficient treatment option that also delivers excellent cosmetic results. Besides being a painless alternative to other procedures, the Rhenium-SCT® also allows the treatment of numerous NMSC lesions consecutively in a single session, which was already realized during the first treatment in Hanau. This has also attracted international attention so that an American patient travelled to Hanau for the treatment.

“This therapy is particularly suitable for tumor localizations where good cosmetic results are to be achieved. The fact that the treatment is completely painless and can be performed in just one session is a great advantage”, says Dr. Lutz-Hendrik Holle, Medical Director of Nuclear Medicine in Hanau.

“We are very happy and proud to be able to offer our revolutionary treatment to patients in Germany now. The interregional professional association of nuclear medicine in Hanau is an excellent partner for NMSC patients in the fight against NMSC”, said Shannon D. Brown III, CEO and Managing Director of OncoBeta® GmbH. “Unfortunately, Germany is one of the countries that has experienced a drastic increase in newly diagnosed NMSC cases in recent years. Our highly qualified team strives to provide physicians and patients with a non-invasive and affordable solution to treat NMSC, while focusing on the needs of the patient.”

The global incidence of non-melanoma skin cancers has been drastically increasing over the past decades. Depending on the source, it is estimated that there are over 5 million non-melanoma skin cancer cases reported globally each year. In certain analyzed areas of Germany there was an increase in the incidence between the year 2005 and the year 2014 by about 30%1. To serve the increasing medical need for innovative therapies in this field and to improve the quality of patients’ lives, OncoBeta® GmbH has developed its innovative Rhenium-SCT® which only require a single application in most of the cases, applied in one single session with excellent aesthetic outcomes.

Via EPR Network
More Healthcare press releases

CoapTech and Fidmi Medical to Collaborate on Groundbreaking G-Tube Systems

Baltimore, MD, 2019-Sep-18 — /EPR HEALTHCARE NEWS/ — CoapTech LLC (Baltimore, MD) and Fidmi Medical, Ltd. (Caesarea, Israel) announced today that they will be collaborating on bringing to market a set of next-generation products for the initial placement and long-term maintenance of gastrostomy tubes (G-tubes). The collaboration between CoapTech and Fidmi will focus on integrating the company’s two technologies and expanding their collective market opportunities.

Gastrostomy tubes, which help patients receive long-term nutritional support, are typically placed endoscopically and need to be replaced every 3-6 months.

CoapTech’s PUMA-G System allows initial gastrostomy tube placement by non-surgeons/ gastroenterologists, outside of the endoscopy suite, using point-of-care ultrasound at the patient bedside. This novel approach can be performed in the ICU, emergency room, and eventually outside of the hospital setting, substantially reducing costs for tube placement.

Fidmi Medical’s innovative low-profile gastrostomy system is unique in that it can be utilized for both initial placement and replacement and has several features which make it more durable and comfortable for patients. Gastrostomy tubes very often get dislodged, clogged, or infected, and need to be replaced frequently. Fidmi’s improved low-profile gastrostomy tube is placed just like any standard PEG tube but has an easily replaceable inner tube which can be changed by patients without the need to re-enter the healthcare system for replacement procedures. This will result in fewer complications with patients’ g-tubes, therefore potentially reducing healthcare costs for payers and healthcare systems; as well as providing a substantial improvement in quality of life for patients and their caregivers.

Fidmi Medical Chairman, Lloyd Fishman, commented, “We are excited to collaborate with CoapTech in development and marketing. Both companies have developed cutting-edge technologies that will improve patient care and contribute to the ease, efficiency and confidence of clinicians’ work in the gastrostomy field.”

Dr. Steven Tropello, CoapTech’s founder and CMO said, “In combination these systems will be compatible with Push or Pull methods, be implantable in a wide variety of clinical settings, and require minimal readmission to the hospital and fewer visits to the ER. The synergy will reduce both front and back-end costs for hospitals and payers, and make care safer and more patient-centered.”

Via EPR Network
More Healthcare press releases

2019 PDA Europe Biomanufacturing Conference in Munich: new speakers announced

2019 PDA Europe Biomanufacturing Conference in Munich: new speakers announced

BERLIN, 14-Aug-2019 — /EPR HEALTHCARE NEWS/ — The Parenteral Drug Association (PDA) today announced representatives of seven health authorities have been invited to speak at the 2019 PDA Europe Biomanufacturing Conference, 3-4 September 2019 in Munich, Germany. The following health authorities have confirmed speakers:

  • Danish Medicines Agency
  • Dutch Medicines Evaluation Board
  • European Medicines Agency
  • European Directorate for the Quality of Medicines & Healthcare (EDQM)
  • Swedish Medicines Agency

Mats Welin, Medical Products Agency, Sweden, and Dolores Hernan, European Medicines Agency, will provide an opening plenary talk on Accelerated Access and discuss the results of a 2018 EMA/FDA workshop on quality considerations for early access approaches. Those intrigued by Accelerated Access can learn more in the follow-up session, moderated by Martjin van der Plas, Dutch Medicine Evaluation Board. Welin and Hernan will participate in a panel discussion ending that session.

After a the first-day luncheon, Nanna Kruse, Danish Medicines Agency, will peel away some of the mystery surrounding the forthcoming International Conference on Harmonization (ICH) Guideline Q12: Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management. In a parallel track, the Austrian Agency for Health and Food Safety (speaker TBD) will intrigue the audience with a review of challenges regulators routinely face with the advent of new vaccines and innovative biologics.

Bright and early on 4 September, the EDQM’s Gwenael Cirefice and the Dutch Medicines Evaluation Board (speaker TBD) turn the attention to ICH and advances in test methodologies. In a parallel track, Martjin van de Plas returns to the podium to review regulatory ideas regarding quality by design and control strategies. Hernan takes the mic as the conference’s last speaker to discuss EMA’s 2025 regulatory science strategy.

The meeting will close with a panel discussion including all the regulatory representatives participating.

Learn more about the topics that will be examined in-depth and/or to register. https://www.pda.org/global-event-calendar/event-detail/biomanufacturing-conference

Members of the press are welcome to apply for a press pass. https://www.pda.org/about-pda/press-pass-request-form

SOURCE: EuropaWire

2019 Red Herring North America Top 100 Winner: New recognition of OncoBeta’s success in developing and providing an innovative therapy for non-melanoma skin cancer patients

Pasadena, CA, U.S.A., 6-Jul-2019 — /EPR HEALTHCARE NEWS/ — OncoBeta®, a Medical Device Company specialized in innovative epidermal radioisotope therapies for Non-Melanocytic Skin Cancers (NMSCs), announced today, that it was honored as a Red Herring Top 100 North America Award winner recognizing the continent’s most exciting and innovative private technology companies. After being recognized with the Red Herring Top 100 Europe Award earlier this year, this is now the second recognition obtained by Red Herring.

The winners, celebrated at a special awards ceremony at the Westin Pasadena hotel, have been chosen from thousands of entrants, whittled down to hundreds making the trip to California. The ceremony, led by Red Herring chairman Alex Vieux, was preceded by two days of keynote speeches, discussions and finalist presentations.

Companies were judged by industry experts, insiders and journalists on a wide variety of criteria including financial performance, innovation, business strategy, and market penetration. Winners ran the gamut of verticals, from FinTech and Marketing to Security, IoT, and many more industries.

Red Herring’s editors have been evaluating the world’s startups and tech companies for over two decades. It gives them the ability to see through the industry’s hype to pick firms that will continue on a trajectory to success. Brands such as Alibaba, Google, Kakao, Skype, Spotify, Twitter and YouTube have all been singled out in Red Herring’s storied history.

“2019’s crop of Top 100 winners has been among our most intriguing yet,” said Vieux. “North America has led the way in tech for so many years, and to see such unique, pioneering entrepreneurs and companies here in California, which is in many ways the heartland of the industry, has been a thrilling experience.”

“What has excited me most is to see so many people forging niches in high-tech and cutting edge sectors,” added Vieux. “Some of the technical wizardry and first-rate business models showcased here at the conference has been fantastic to learn about. We believe OncoBeta® embodies the drive, skill and passion on which tech thrives. OncoBeta® should be proud of its achievement – the competition was incredibly strong.”

“Being named as one of the Red Herring’s Top 100 North America award winner in addition to the Top 100 Europe is a great honor for us.” states Shannon D. Brown III, CEO of OncoBeta®. “The spirit of the award aligns perfectly with our team’s mission in the fight against non-melanocytic skin cancer (NMSC) with the Rhenium-SCT®.”

The complete list of the 2019 Red Herring North America Top 100 Winners can be found here in alphabetical order: https://www.redherring.com/2019-rhna-top100-winners/

Red Herring’s press release is available online at https://www.redherring.com/red-herring-2019-top-100-north-america-winners-press-release/

SOURCE: EuropaWire

EMA, MHRA and U.S. FDA among regulatory agencies participating at PDA’s 4th Annual European Meeting in Amsterdam

BERLIN, 10-Jun-2019 — /EPR HEALTHCARE NEWS/ — The Parenteral Drug Association (PDA) is excited to host its 4th Annual European Meeting: Global Healthcare of the Present and the Future, June 25-26 in Amsterdam, The Netherlands, the new location of the European Medicines Agency, where industry and regulatory agencies will present their perspectives on the transformation unfolding in the pharmaceutical sector regarding the digitalization and automation of manufacturing processes.

From the Max Planck Institute for Human Development, Felix G. Rebitschek will deliver the keynote speech, “Decision-Making Under Uncertainty.” Following him, the opening plenary “Regulatory Updates – Current Situation” will discuss understanding regulatory frameworks in an atmosphere of rapid change and provide the opportunity to participate in conversation with regulators and industry representatives.

Regulatory agencies sharing industry updates include the European Medicines Agency, U.S. FDA, WHO, MHRA and HPRA, PIC/S.

A series of parallel tracks will offer the chance to learn about topics ranging from virtual reality, data quality management, manufacturing technologies and much more.

Learn more about the topics that will be examined in-depth.

Registration (https://store.pda.org/Meetings/Login.aspx?ID=4520) can be completed until June 24.

Bona fide members of the press are welcome to apply for a press pass.

SOURCE: EuropaWire

2019 PDA EU Advanced Therapy Medicinal Products: Cell and Gene Therapy – From Promise to Cure Conference

BERLIN, 28-May-2019 — /EPR HEALTHCARE NEWS/ — The Parenteral Drug Association (PDA) is pleased to announce the speaker lineup for the 2019 PDA EU Advanced Therapy Medicinal Products: Cell and Gene Therapy – From Promise to Cure Conference, in Vilnius, Lithuania, June 4-5. Expert speakers representing industry, government and academia will cover the full breadth of scientific and regulatory considerations for successfully launching and manufacturing cell and gene therapies.

Lithuanian University of Health Science professor Romaldas Maciulaitis will get the meeting off to a quick start with his presentation, “Development and the Use of ATMPs in EU/Lithuania.”

Following him in the opening plenary session is Alistair Gibb from the UK Medicines and Healthcare Products Regulatory Agency, presenting “ATMPs System-wide Challenges from Innovation to Uptake – Pragmatic Supportive Regulation and Standards.”

The Paul-Ehrlich Institute’s Isabelle Bekeredjian-Ding takes the podium after her British counterpart with, “From Individualized to Standardized Microbiological Quality Control in ATMP Manufacturing.”

The PDA EU ATMP Conference comes just a month after PDA’s successful Cell and Gene Therapy Conference in Long Beach, Calif., May 6 – 7. That conference drew 200 participants. Earlier this year, PDA published Technical Report No. 81: Cell-Based Therapy Control Strategy.

Go here to see the full speaker lineup.

Press passes are available here to bona fide members of the press.

SOURCE: EuropaWire

The interregional professional association for nuclear medicine in Hanau has become the first treatment center in Germany to offer the Rhenium-SCT® (SCT= Skin Cancer Therapy)

GARCHING N. MUNICH, Germany, 13-May-2019 — /EPR HEALTHCARE NEWS/ — OncoBeta® GmbH, a commercial stage Medical Device Company specialized in innovative epidermal radioisotope therapies for Non-Melanocytic Skin Cancers (NMSCs), is pleased to announce that the interregional professional association for nuclear medicine in Hanau now offers the Rhenium-SCT ® (SCT= Skin Cancer Therapy) as the first treatment center in Germany.

With approximately 50.000 outpatient examinations annually, the interregional professional association for nuclear medicine Hanau is one of the biggest nuclear medicine service providers in Hesse. The offered services include a variety of different modern treatment and diagnostic methods which are state-of the art in science and technology.

“Offering NMSC skin cancer patients a highly efficient, painless, innovative therapy with excellent aesthetic results was the driving reason to establish this treatment method in our clinic,” says Dr. med. Lutz-Hendrik Holle, Medical Director of Nuclear Medicine in Hanau.

“We are delighted that our innovative skin cancer therapy Rhenium-SCT® is now being offered by the Nuclear Medicine in Hanau and we are looking forward to this collaboration”, states Shannon D. Brown III, CEO and Managing Director of OncoBeta® GmbH. “For us, this is an important step to offer the treatment method in addition to Italy, South Africa and Australia now also in Germany. In order to provide our treatment to as many skin cancer patients as possible, it is of course our goal to offer the availability of the therapy nationwide in Germany in the future.”

The global incidence of non-melanoma skin cancers has been drastically increasing over the past decades. Depending on the source, it is estimated that there are over 5 million non-melanoma skin cancer cases reported globally each year. In Germany the number of newly diagnosed patients is about 200,000 annually and it is assumed that this number increases within the next years. To serve the increasing medical need for innovative therapies in this field and to improve the quality of patients’ lives, OncoBeta® GmbH has developed its innovative Rhenium-SCT® which only require a single application, applied in one single session with excellent aesthetic outcomes.

If interested, patients and doctors can either contact the interregional professional association for nuclear medicine in Hanau directly or OncoBeta® GmbH.

SOURCE: EuropaWire

University of Pretoria Prof. Mike Sathekge is First in South Africa to Treat Non-Melanocytic Skin #Cancer Patients with Rhenium-SCT®

Garching n. Munich, Germany, 26-Nov-2018 — /EPR HEALTHCARE NEWS/ — OncoBeta® GmbH, a commercial stage Medical Device Company specialized in innovative epidermal radioisotope therapies for Non-Melanocytic Skin Cancers (NMSCs), announced today that Prof. Mike Sathekge from the University of Pretoria, Steve Biko Academic Hospital Nuclear Medical department and his clinical team has treated the first non-melanocytic skin cancer patients in South Africa with the innovative Rhenium-SCT® skin cancer treatment System. This next-generation radionuclide therapy technology applied by the nuclear medicine physician offers a new singles session, painless treatment for patients suffering from Basal Cell – and Squamous Cell Carcinomas (BCCs and SCCs).

The global incidence of non-melanoma skin cancers has drastically increased over the few past decades. Depending on the source, it is estimated that there are over 5 million non-melanoma skin cancer cases reported globally each year. Approximately 80% of non-melanoma skin cancers are basal cell carcinomas or squamous cell carcinomas with South Africa having one of the highest incidence rates in the world.

Prof. Mike Sathekge and his team at the University of Pretoria, Steve Biko Academic Hospital are focused on providing patients with personalized care using state-of-the-art technology that can deliver high-precision therapy and diagnostics with minimal side effects. The specialized team of experts in the nuclear medicine and medical physics, work closely with other disciplines within the university hospital, referring physicians, and other institutions, to ensure patients receive the best possible treatment for their specific type of cancer.

Martin Magwaza, CEO of Tautomer (PTY) LTD Oncobeta®’s distribution partner for the Rhenium-SCT® in Africa, is dedicated to providing South Africans with new innovative and effective therapies across the continent, coordinating with representatives from all levels of government and state for the health care landscape.

“The start of the Rhenium-SCT® in South Africa is a significant milestone in the international expansion of our ground-breaking treatment for BCCs and SCCs.,” said Shannon D. Brown III, CEO and Managing Director of OncoBeta® GmbH. “Our vision of bringing a revolutionary affordable skin cancer therapy to physicians and patients all over the world has come one step closer today”.

SOURCE: EuropaWire

Europe Home Diagnostics Market: Growth in Pregnancy and Ovulation Predictor Test Kits Sales Encouraging

DUBLIN 2, Ireland, 18-Oct-2018 — /EPR HEALTHCARE NEWS/ — The European home diagnostics industry is realigning to foster integration with the broader customer-centric healthcare services. Growing consumer preference for home-based diagnostics, combined with innovation in online platforms, is creating sustained opportunities in this dynamic landscape. Riding on the coattails of these factors, the US$ 1.4 billion Europe home diagnostics market is likely to grow at 3.4% CAGR during the period 2018-2026.

Consumer Preference for Non-Invasive Glucose Monitoring Devices Still Remains Unmet 

Glucose monitoring kits and devices remain the top-selling product, accounting for over 80% revenue share of the Europe home diagnostics market. The burgeoning demand for home-based glucose monitoring devices and kits can be attributed to growing prevalence of diabetes in Europe, which is increasing across all ages according to the WHO. The Fact.MR study opines that digital devices will remain the preferred choice over cassettes among European consumers.

The broader trends pertaining to non-invasive and painless diagnostics are driving innovation in glucose monitoring device development. According to the Fact.MR study, non-invasive glucose monitoring devices are likely to witness increasing penetration in Europe, albeit at a slow pace. The report also finds that broader innovation in non-invasive devices can drive healthcare consumerism across Europe.

Request a sample of the report

https://www.factmr.com/connectus/sample?flag=S&rep_id=1892

The Fact.MR study remains optimistic on the future growth in Europe’s home diagnostics market, however, challenges prevail. “Self-testing, especially for people with type 1 diabetes, who require daily or frequent testing, remains a painful and inconvenient process. Over the decades, the innovation in glucose monitoring devices hasn’t really addressed the invasive part of the self-testing”, says Mr. Santosh Kumar, Senior Consultant at Fact.MR. “There is an urgent need for non-invasive glucose monitoring testing,” adds Mr. Kumar.

The Fact.MR study finds that home diagnostics manufacturers are aware of the evolving demand. Investment and research into developing minimally or non-invasive home diagnostics devices is gaining ground. “The realization that digital, and non-invasive devices are the future is dawning upon manufacturers. Market leaders, such as Siemens Healthcare and Abbott Technologies are leveraging wearable technologies and IoT to develop innovative products,” says Mr. Kumar.

Growth in Pregnancy and Ovulation Predictor Test Kits Sales Encouraging 

Although glucose monitoring devices and kits will account for the majority of sales, encouraging trends in other self-test kits continue to complement market growth. Pregnancy test kits and ovulation predictor test kits are likely to witness surging demand, as an increasing consumer base feels confident about self-testing. Gains are also encouraging, albeit miniscule, in other home diagnostics products, such as urinary tract infection kits and male infertility test kits.

UK Maintains its Numero Uno Position, Germany and France Remain Lucrative

The Europe home diagnostics market remains concentrated in the UK, Germany, and France. These three markets collectively account for a market share of nearly 60% revenue share of the Europe home diagnostics market. The Fact.MR study opines that these three markets will witness increasing proliferation of next-gen home diagnostics devices.

Request methodology behind the report

https://www.factmr.com/connectus/sample?flag=RM&rep_id=1892

Fact.MR study on the home diagnostics market brings interesting insights to the fore. According to the report, UK remains Europe’s largest market for home diagnostics, with revenues to the tune of US$ 280 million in 2017. The study opines that UK will maintain its numero uno position throughout the course of the forecast period 2017-2026. Germany and France will follow suit, however, sales will grow at a sluggish pace in the former.

The report also finds that home diagnostics devices that use urine and blood for testing will continue to remain pervasive in the Europe home diagnostics market. Samples devices and kits that use semen and breath are expected to witness growth during the course of the forecast period.

Buy the report

https://www.factmr.com/checkout/1892/S

SOURCE: EuropaWire

IBM Watson Market Study: IBM Watson services have been positively disrupting and reforming operations in the healthcare industry

DUBLIN 2, Ireland, 10-Oct-2018 — /EPR HEALTHCARE NEWS/ — IBM Watson Services continue to get significant traction from end-users, with over 72% respondents in Europe affirmative on using IBM Watson language services, according to a Fact.MR survey. The survey is part of the comprehensive research study on IBM Watson services market which tracks the adoption of this platform across key sectors. The Fact.MR survey also reveals that use of IBM Watson vision services attracted the minimum interest, with only 48% of respondents in Europe affirmative about using it.

Fact.MR’s IBM Watson services market survey gathered data from over 500 respondents in 10 European countriesThese respondents represented large-scale, SMEs, and micro organizations, with a collective IT spending budget of over US$ 50 billion. The findings of the survey were in sync with the overall expectations and use of IBM Watson services, which are highly reliant on revenue generated from language services.

Growing Realization that Cognitive Technologies Can Empower Decision-Making 

The survey indicates that mitigating the gaps that exist in IT vendors’ execution from data collection to action remains the key concern of organizations. There is an increasing realization among IT vendors that cognitive technologies can empower decision-makers to make sense of colossal structured and unstructured data. The survey offers encouraging insights on the growing use of advanced analytics and cognitive computing in today’s data-driven economy, as over half of the respondents in the survey agreed to using insights- and speech-services of IBM Watson.

Request Sample of IBM Watson Services Market Report at https://www.factmr.com/connectus/sample?flag=S&rep_id=759

“Today, the requirements of organizations are multi-pronged – from gaining a holistic customer view to agile data-to-execution operations, organizations need to invest in cognitive computing and advanced technologies to stay competitive,” says Shambhu Nath Jha, Senior Consultant at Fact.MR and co-author of the study.

“IBM Watson services have been positively disrupting and reforming operations across sectors, especially healthcare. From screening patient’s structured and unstructured data to regulatory requirements and medications, IBM Watson services are witnessing extensive adoption in the healthcare sector,” added Mr. Jha. The growing adoption of IBM Watson services in healthcare is further substantiated by Fact.MR’s findings that the sector currently accounts for nearly 21% revenue share, representing a market value worth US$ 318 Mn.

Improved Business Agility and Seamless Customer Service Identified as Key Advantages 

The Fact.MR survey further reveals that improvement in business agility is the most prominent motivation driving investment in IBM Watson services. Nearly 84% of respondents currently using IBM Watson services said that there was a marked improvement in business agility since the introduction of platform in their organization. An additional 82% said IBM Watson services helped their organizations in improving and transforming customer service.

“Customer service has often remained a key concern for organizations; despite the proliferation of advanced technologies and pervasiveness of smartphones, nearly 50% of customer support calls remain unresolved,” says Shambu Nath Jha. “The integration of artificial intelligence (AI) can mitigate this challenge, and offer seamless support for Tier 1 queries. The system can also effectively gauge the queries that require human intervention, and escalate those queries to a customer support executive if necessary,” adds Mr. Jha.

Know the methodology behind the report 

https://www.factmr.com/connectus/sample?flag=RM&rep_id=759

Effective decision-making, handling colossal structured and unstructured data, and sales assistance are among the other key advantages of using IBM Watson services, according to the Fact.MR survey. “Effective decision-making entails a deep understanding of the unique needs and requirements of customers. Today, businesses are hard-pressed to understand the unique characteristics of their customers, and effectively map their existing and upcoming products to meet the overt and covert needs. IBM Watson can provide sophisticated recommendations that can facilitate effective decision-making,” Mr. Jha added.

Fact.MR’s report on the global IBM Watson services market projects a surge in investments to mitigate cybersecurity risks. According to Fact.MR, a majority of organizations have some level of cybersecurity apparatus in place. However, as Mr. Jha concludes, “tackling the potent cybersecurity threats will require a comprehensive ecosystem, rather than a symbolic front-line defense.”

The IBM Watson Services Market Report is Available for Direct Purchase at

https://www.factmr.com/checkout/759/S

SOURCE: EuropaWire

How Type 2 Diabetes Can Be Cured

VANCOUVER, B.C., May-31-2018 — /EPR Healthcare News/ —  The mission of the International Diabetes Federation (IDF) is to promote diabetes care and cure worldwide. Type 2 diabetes, once thought only to afflict African descends, other minorities, and the less educated, is now an ignored pandemic afflicting over 450 million people from diverse academic backgrounds and races, worldwide. Health Department budgets allocated for managing diabetes in developed nations each year is staggering; far exceeding the GDP of most other countries. In a new book titled Diabetic’s Journey, diabetes survivor and expert, Ernest Quansah, demystifies how type 2 diabetes can be cured.

In his book, Quansah chronicles circumstances that led him to crave and heavily indulge in sugar, one day awaking to find a sticky, whitish substance in the corners of his eyes and on his tongue. Upon reviewing Quansah’s blood tests, his doctor used these words: “Do you know the danger you have put yourself in? You are not far from going into cardiac arrest. The whitish substance is sugar build-up in your body trying to find a way out.”

Quansah’s research uncovered two lifesaving pieces of information:

  1. Type 2 diabetes is caused by consumption of refined sugar; a fact confirmed by Dr. Sanjay Basu, Ph.D., of Stanford University.
  1. Natalia McInnes of McMaster University, type 2 diabetes cure researcher, stated that type 2 diabetes can be reversed  and cured in four months.

Said Quansah, “My doctor supported Dr. McInnes’s findings when he said to me: ‘Type 2 diabetes is cured using several approaches all working together. The diabetes is cured if it does return two years after reversal.’ Reversing type 2 diabetes costs less than $200.00 per diabetic, a fraction of what is spent each year managing diabetes for the rest of one’s life. This is not taking into account the added cost of the onset of other diseases resulting from the diabetes. Best of all, the victim’s life will be saved when he or she is cured. One becomes type 2 diabetic when sugar builds up in the body and converts into fat. Some of the fat finds its way into the bloodstream. It coats red blood cells preventing them from absorbing sugar and transporting it to the muscles to be used as energy. The pancreas still works; however, the insulin it secretes is not able to transport the excess sugar. The excess sugar buildup causes heart disease, kidney failure, nerve damage, blindness, etc.: Diabetes simply forecasts these pending diseases. The solution is simple. To reverse type 2 diabetes, the sugar buildup in the body and the fat coating the cells must be expelled, allowing for normal cell function.”

Quansah developed:

  1. A customized weight-reducing menu cycle
  2. A customized fat and sugar burning exercise routine
  3. A vitamin/supplement regime to protect the heart

When asked about his own response to his program, Quansah said, “Within a month of applying the above factors, my energy level surged. My doctor ordered another blood glucose test. ‘Look at your test results,’ Dr. Robinson said. ‘Congratulations. You are no longer a diabetic.’ My life was saved. I told him that I must write a book to help other diabetics. He replied, ‘that’s an excellent idea.’”

Quansah’s book, Diabetic’s Journey, is endorsed by a professor of diabetology and medicine. Reviewers gave his book a rating of 8.8/10.

Proof that type 2 diabetes can be reversed: WebMD, the leading healthcare information provider to doctors and consumers, interviewed Quansah and published an article about his diabetes cure methodology in WebMD Diabetes Fall 2016 issue, page 19, and on their website. The article was titled, Secret recipe: How a Chef Cured His Type 2 Diabetes . Additionally, Clyto Access contacted him to produce a video presentation on How Type 2 Diabetes Can be Cured to be presented at the International Diabetes and Degenerative Disease conference. His paper titled, The Case Against Managing Type 2 Diabetes is posted on Academia.edu and has been viewed and downloaded by researchers worldwide.

Quansah’s book’s subtitle, How Type 2 Diabetes Can be Reversed and Cured, amplifies what doctors say. Quansah says, “The mission of the Just for Diabetics website is to promote diabetes care and cure by offering pre-diabetics and type 2 diabetics the tools to reverse and cure themselves. Proceeds provide funding to humanitarian efforts and for developing products for diabetics.”

###

Ernest Quansah is available for interviews.

Email: ernestq@ernestquansah.com

Cell: 1-778-229-8049

Diabetic’s Journey is available from:

Amazon: ISBN- 978-0994767042

Website: https://justfordiabetics.com

Sway Medical’s app for sports concussion exam received European CE Mark as Medical Device

sway-concussiontest-is-a-validated-ios-app-based-concussion-management-system

TULSA, OK, 08-Sep-2016 — /EPR HEALTHCARE NEWS/ — Sway Medical is a US medical device company who’s software turns an iPhone or iPad into a mobile medical device that provides immediate medical grade, objective concussion measurement to medical professionals.

Sway Medical LLC (Sway) would like to announce its official availability in all European Union Countries. Sway was issued its CE Mark after being marketed in the United States and Canada for two years. This is significant because European sports organizations ranging from youth through pro level now have an affordable and convenient sideline assessment tool supporting concussion related medical decision making. Medical professionals and trained coaches can obtain a concussion assessment via an Apple mobile device (iPhone or iPad) and the Sway Balance™ System web-portal. Acute objective measurements are obtained by performing a 1.5 minute balance and reaction time test protocol. Licensed athletic trainers, physical therapists and athletic therapists are able to join physicians in acutely managing the underserved market of youth sports, ages six and older.

Concussion injuries are very common in sports, often going un-reported or ignored until the obvious symptoms have incapacitated the athlete or draws the attention of a parent or coach. Second Impact Syndrome (SIS) is a serious medical condition with published mortality rates of up to 50%. SIS occurs when an athlete returns to play while still recovering from an initial concussion injury. During this time, the brain is highly susceptible to additional injury and complications. The Sway Balance™ System is able to accurately assess and track the acute and chronic outcome related to an athlete’s balance, motion reaction time and concussion symptoms. The Sway Balance™ System provides a graphical representation comparing suspicious injury event tests against a pre-injury “normative” or baseline score. The comparison of event tests against an established baseline is a common measurement for traumatic brain injury diagnosis and recovery tracking.

The Sway Balance™ System is available for purchase by licensed medical professionals involved in school, occupational or sports medicine through www.swaymedical.com. Additional protocols are available to assess an individual’s “Fall Risk” or “Functional Status”.

SOURCE: EuropaWire

Medical Scribe Systems Named to Inc. 5000 List for Fastest Growing Private Companies in America

Medical Scribe Systems (MSS) is recognized as one of America’s fastest growing private companies by Inc. magazine. MSS has doubled its growth every year since 2011, while also improving customer satisfaction.

El Segundo, CA – 2014-8-21 — /EPR Healthcare News/ —  Medical Scribe Systems (MSS), the nation’s leading provider of scribe programs specializing in revenue cycle enhancement, has been chosen for Inc. 500|5000, an exclusive ranking of the nation’s fastest-growing private companies, published annually by Inc. magazine.

Medical Scribe Systems
Medical Scribe Systems

“We are thrilled to have made such a prestigious list alongside other successful, hardworking organizations,” says CEO Garret Erskine. “It is a testament to the effectiveness of the MSS scribe program in improving physician productivity, clinical documentation, and patient satisfaction.”

“The company was started by four physicians with a simple idea,” says Erskine. “By offloading the data entry component of their work, they quickly discovered how to stay focused on patient care by positively impacting patient interaction, clinical efficiency, and the quality of documentation in the Electronic Medical Record (EMR).”

The recognition of MSS as one of Inc.’s “Fastest Growing Private Companies” comes at a time as the Company has doubled its client base within the last year, while at the same time improving customer satisfaction.  The company now has over 2,000 scribes serving nearly 100 facilities across the nation.

“MSS is focused on data integrity, charge capture, and revenue cycle solutions ensuring that our scribe program actually pays for itself,” says Erskine.  “Our unique approach integrates the scribe program into the customer’s Revenue Cycle and Clinical Documentation Improvement processes.  MSS partners with customers to address data quality issues at the time and point of care.”

For more information about Medical Scribe Systems, visit http://www.medicalscribesystems.com or email info@scribesystems.com.

About Medical Scribe Systems

Medical Scribe Systems, the nation’s leading provider of scribe programs focusing on revenue cycle enhancement, provides real-time documentation services for emergency departments, outpatient clinics, and hospitalists nationwide. The company founders are board-certified physicians who started their first scribe program in 2003. Board members Dr. Mark Richmond and Fred Brown, the former Chairman of The Joint Commission, helped establish the first guidelines for scribe use and compliance.  Now in nearly 100 hospitals nationwide and employing more than 2,000 scribes, Medical Scribe Systems has doubled growth each year since 2011.

Contact:
David Fong
Director of Marketing
dfong@scribesystems.com
(877) 819-5900

###

Medical Scribe Systems has doubled its growth every year since 2011. Today, the company employs about 2,000 scribes in nearly 100 hospitals and outpatient clinics nationwide.
Medical Scribe Systems has doubled its growth every year since 2011. Today, the company employs about 2,000 scribes in nearly 100 hospitals and outpatient clinics nationwide.
MSS medical scribes are becoming a best practice for clinical documentation on the Electronic Medical Record. They improve revenue cycle by capturing all billable elements in real time.
MSS medical scribes are becoming a best practice for clinical documentation on the Electronic Medical Record. They improve revenue cycle by capturing all billable elements in real time.

Health Gorilla Releases Mobile Application for Doctors

Digital Health Leader Expands Marketplace Access with Mobility

SUNNYVALE, CA., 2014-8-20 — /EPR Healthcare News/ — Health Gorilla™, Inc., the first online healthcare marketplace to connect doctors and clinicians with over 9,000+ diagnostic labs and 35,000+ radiology centers, has announced today the release of Health Gorilla mobile.  Health Gorilla mobile provides access to the Health Gorilla Marketplace through the Apple® iPhone® and iPad™.

Today over 68% of doctors have standardized on the Apple platform to communicate with peers and patients. Doctors can now use their mobile devices to place electronic orders with Health Gorilla mobile to diagnostic labs, radiology centers, physical therapy, skilled nursing facilities (SNFs) and durable medical equipment (DME) and other medical providers nationwide with the ability to track and review the results instantly as they arrive.  Physicians can then forward electronic results within their practice or exchange them with peers and patients to streamline the process and improve quality of care.

According to a study published by the New England Journal of Medicine noted that approximately 59.3% of all of a primary care physician’s daily emails were for the interpretation of test results and 21.7% were responses to patients.  The use of email generally increases the risk for doctors and their patients as most email services are not HIPAA compliant.

Another study published in the Journal of the American Medical Association (JAMA) reported that researchers from the Michael E. DeBakey Veterans Affairs Medical Center in Houston conducted a survey of primary care practitioners and found that a third reported missing alerts about test results from an electronic health record notification system designed to inform them when a patient has abnormal test results.

Doctors are adopting iPad and iPhones as the platform of choice to communicate with peers and patients. Health Gorilla mobile integrated messaging greatly reduces the risk in communication between a doctor and their patients by offering a fully HIPAA compliant environment. Health Gorilla mobile enables a physician to securely and compliantly forward diagnostic test results, radiology images, admission and discharge summaries and other clinical documents to patients and care coordinators through secure messaging.

Benefits of Health Gorilla Mobile Include:

  • HIPAA compliant and ONC modular certified MU2 solution
  • Order in less time than it takes to use fax forms
  • Receive results faster wherever you are
  • Forward results to patients instantly
  • Immediately refer results to another doctor and send messages
  • Eliminate error prone paper processes
  • Mobile solution available at no charge for doctors and their teams

“We believe that the value proposition is clear and compelling for doctors and their teams.” said Steve Yaskin, Chief Executive Office, Health Gorilla, Inc.  “The existing process is heavily dependent on paper, fax and manual processing.  It is slow, cumbersome and prone to error.  Doctors can better manage their time, and the time of their administrative and care coordinating teams, by using the power of the marketplace through the Health Gorilla app.  Now they have one place to order from any diagnostic lab, radiology center, hospital, physical therapy, sleep center, SNF and other healthcare providers in the United States.  A doctor can start with us the first day and begin ordering through the marketplace immediately.  Health Gorilla is the first to deliver this capability.  No other vendor can provide this benefit.”

Health Gorilla mobile is available as an approved Apple® enterprise application and will be distributed to existing Health Gorilla Marketplace users via a secure link for the next month.  In September Health Gorilla mobile app will be available from the Apple® store and will be fully integrated with the Apple® Health app upon its release.

About Health Gorilla
Health Gorilla™ is the first online healthcare marketplace to connect all doctors and clinicians with over 9,000+ diagnostic labs and 35,000+ radiology centers.  Doctors and their teams can instantly place orders, get results, and completely eliminate paper faxes. Uniquely, our HIPAA compliant and ONC modular certified MU2 solution is available immediately at absolutely no charge for doctors and clinicians.

Watch our 2 minute video Intro to Health Gorilla: http://youtu.be/6Luo5eNG8-s
Tweet: https://www.twitter.com/healthgorilla
Facebook: https://www.facebook.com/healthgorilla
LinkedIn: https://www.linkedin.com/company/2542523?
Sign-up for our Newsletter at the bottom of homepage:
http://www.healthgorilla.com

Contacts

For additional information contact Joe Austin via jaustin@theventanagroup.com or call 818-332-6166.

Health Gorilla™ is a trademark of Health Gorilla, Inc.
Apple®, iPhone®, iPad mini™ are trademarks of Apple, Inc.

Health Gorilla Releases Mobile Application for Doctors
Health Gorilla Releases Mobile Application for Doctors

Leaky Gut Cure Through Holistic Nutrition Announced

Sufferers of leaky gut syndrome will be cheered by Karen Brimeyer’s announcement of a program called “Leaky Gut Cure” that can relieve symptoms and ease suffering from the crippling digestive track disorder. Based on healthy lifestyle recommendations, this holistic cure is based on dozens of effective ideas evolved over stringent testing and experimentation.

Nearly 2 million people have leaky gut syndrome, a poorly defined and often under-diagnosed gastro-intestinal system disorder that causes belly aches, bowel disturbance and food sensitivities. Patients often complain of abdominal cramps, bloating, flatulence and indigestion. Tired of one fad diet after another, people who have silently suffered from the condition will find this leaky gut syndrome cure the answer to a prayer.

“Obviously this system is based on extensive testing, and the author has clearly tried these methods out herself before suggesting it to others,” opined one of the early reviewers who thought the 5-point program was likely to help her. Many others who have undergone the holistic program have echoed similar sentiments.

The system called “Leaky Gut Cure” was devised by Karen Brimeyer who is a holistic nutritionist and functional medicine practitioner. It is based on a five part sequence of advice that has been shown to reverse or at least mitigate leaky gut syndrome with all her own clients. The newly packaged course takes this information out to a new audience across the world.

“The health of your gut is important in your overall health and well being” says Karen. “Leaky Gut Cure is powerful information for anyone who could be having undetected gastrointestinal disorders resembling the syndrome.”

Many effective treatments and lifestyle changes are revealed in this guide, including 3 health foods that are widely recommended and consumed by millions of people daily, but that could make the symptoms of leaky gut syndrome worse. Considering how beneficial it is to sufferers, the program is affordable and widely accessible. Victims of leaky gut can get the information without wasting hundreds, or even thousands of dollars on expensive doctor visits or costly tests to detect and monitor disease progress.

Karen Brimeyer is giving away a free report that shares three effective techniques for leaky gut cure from her website. For more information about the Leaky Gut Cure go to http://www.LeakyGutCureReview.org

Contact Details: LeakyGutCureReview.org
Optibiz Publishing, P.O.Box 90012,
Chennai, TN 600107
info@LeakyGutCureReview.org
http://www.LeakyGutCureReview.org

Via EPR Network
More Healthcare press releases

Want Vibrant Wellness? Free talk by Encinitas physician December 4th

Dr. Diana Hoppe, Encinitas Ob/Gyn physician, is giving a free talk at the Kaila Beauty Bar and Med Spa in Encinitas on Wednesday, December 4, 2013 from 5:30pm-7:30pm.

If living a vibrant life is on your to-do list, you’ll want to learn what this well-known physician has to say about your taking charge of maintaining good health. While we are living in a “toxic soup,” Dr. Hoppe, who is an integrative physician, believes that healthy aging is attainable.

Dr. Hoppe will talk about how to support the body’s ability to cleans toxins so cells can be nourished using positive thinking, exercise, healthy foods, and valuable supplements. Dr. Hoppe says, “It is my sincere desire to help individuals feel, live and perform their very best.”

A highly respected clinical researcher and popular public speaker, Dr. Hoppe earned her medical degree at the University of California, San Diego, where she also completed her internship and residency in Obstetrics/Gynecology.

Dr. Hoppe is a distinguished physician who has practiced integrative medicine in Encinitas since 1989. Among her many accomplishments, she wrote a book called “Healthy Sex Drive, Healthy You,” writes a weekly newsletter and blog, spoke on the Dr. Oz Show, and San Diego Living Show (www.youtube.com/watch?v=R1NCazPmriI (Preview)). She is hosting a seminar with four other doctors called “Vibrantly You” on Jan. 18, 2014. Her website is www.DrDianaHoppe.com

Dr. Hoppe will discuss the hormonal aspects of stress and toxins, and why they make us sick, tired and fat. Focusing on how to de-toxify and help the body to reach optimal health and weight, she will suggest the use of simple core supplementation to support and nourish our inner environment so the body can start to heal itself.

As a physician who is known for wanting to empower her clients to take responsibility for their wellness, after a great deal of investigation, Dr. Hoppe decided to work with the company called Orenda International. Dr. Hoppe found that Orenda is a highly ethical company, endorsed by other reputable doctors. In her research, Dr. Hoppe found that Orenda International uses a paradigm shift called “Awaken, Cleanse and Feed” that supports healthful aging.

Having offered herself as a “guinea pig” to try the new Orenda “Clean Burn Shape” program for effective weight loss, Dr. Hoppe found she could actually shed—without difficulty–17 pounds that she previously failed to get rid of no matter how many different programs she tried to adhere to and found to be unsuccessful. “It is so rewarding to be able to slender down and wear clothes that have been too small for a number of years—especially with the added benefit of having more energy!”

Dr. Hoppe says, “We have the honor of having George Hall, one of the co-founding brothers of Orenda International, join us for the evening.” Hall will share his insights about how to maintain optimal health and will be available to answer questions about the products and the company. Dr. Hoppe adds, “George is not only full of information and positivity—but he makes difficult information easy to understand using his keen sense of humor to keep us entertained while learning.”

The public is cordially invited to attend this 90 minute talk to learn how stress and toxins can impact health and the aging process. Question and answers will follow. Learn how Dr. Hoppe addresses the toxic overload we are all being subjected to, no matter how pure we try to be.

The Orenda website is available for perusal. For those interested in learning about the products or the “People Lifting People” philosophy of the Orenda International company, see “Addressing the Host” and other videos at www.ThisIsOrenda.com/DrDianaHoppe

This talk is free and the general public is welcome. Doctors, acupuncturists, massage therapists and other health professionals who are interested in helping their clients improve their health, cleans their bodies and/or lose weight are specifically invited to attend. To inquire about Dr. Hoppe’s “Vibrantly You” January seminar or RSVP for this free talk call Dr. Hoppe’s office: (760) 635-5600. The location of the Dec. 4 event, the Kaila Beauty Bar and Med Spa, is 282 N El Camino Real Suite D, Encinitas CA 92024. The phone number is (760) 944-4206.

Orenda healthy chocolate, tasty shake, and high anti-oxidant aronia berry juice will be offered to sample at the Wednesday night talk.

Via EPR Network
More Healthcare press releases

20 cm Long Worm In The Human Eye, First Ever Recorded On Video

Can you believe that a 20 cm worm can house itself in the human eye? But one has to believe one’s eyes.

Here is the video clip of a 20 cm long worm being removed from a human eye through surgical procedure. It is the first time ever that such a long worm growing in the eye has been recorded. The video has evoked great interest among medical students as well as the general public.

http://www.indiavideo.org/health/loa-loa-worm-removing-surgery-8857.php 

Dr. Ashley Thomas Mulamoottil, the doctor who recorded this unique surgery says that this is the seventh worm that he has removed in the last one decade and it is also the longest.

The worm Loa Loa was originally found in Africa and has now reached Asia. The mangrove fly or deer fly is believed to be the carrier of this worm. The eggs of the worm enter the human body through small wounds inflicted by the fly. The death of the worm inside the body could be fatal as it could contaminate the blood. The disease is known as microfilariasis or Loa Loa infestation (Loiasis).

The video portal www.indiavideo.org and the Indian language portal www.oneindia.in are taking the video to the world. According to Mr. M.R. Hari, Executive Editor of India Video, the process recorded by Dr. Ashley fetched 2 million views on Facebook in three days and this persuaded them to make a short movie with supporting information to make it useful. Loa Loa disease could be a major health problem in future and hence an awareness campaign is the need of the hour. ‘We take up that mission now’ says

Mr. Sriram Hebbar, CEO of One India.

Via EPR Network
More Healthcare press releases

New study grant seeks understanding of genetics and alcoholism correlation

The National Institutes of Health (NIH) recently awarded a grant for research into the correlation between genetics, environment and alcoholism.

Researcher Tatiyana Apanasovich hopes to find evidence that supports her theory that hypothesizes that 40% to 60% of alcohol dependence is caused by genetic factors as well as environmental factors. She bases her hypothesis on recent discoveries regarding the correlation of overeating and addiction.

“We congratulate Ms. Apanasovich on receiving this grant to study alcoholism,” begins a spokesperson for Mountainside Drug Rehab and Alcohol Treatment Center. “We look forward to seeing her findings and hope that it will provide new information that will help in addiction treatment for individuals.”

If you suspect that someone in your life has a problem with alcohol misuse, it’s important to find medical professionals and licensed counselors and social workers who understand the deadly consequences of prolonged alcohol abuse. Mountainside Drug Rehab and Alcohol Treatment Center can help you in gently approaching your loved one with professional intervention services that can help save them before their addiction claims their life.

Mountainside Drug Rehab and Alcohol Treatment Center is a modern drug rehab facility that is skilled in serving a variety of clients with various addictions and in varying stages of addiction. The caring, compassionate team is made up of licensed and certified social workers and counselors who have extensive experience and specialty in the addiction treatment field. In addition, the staff includes a Nurse Practitioner, as well as a Registered Nurse, both of whom also have specializations and experience within the field of addiction treatment and alcohol rehab.

Mountainside can also make available, for those individuals who come to them with dual diagnoses, the services of a Psychiatrist to help conquer the unique challenges that dual diagnosis brings.

For the past 13 years, Mountainside has established itself as an innovator within the addiction treatment field, and the treatment modalities Mountainside utilizes are regarded as among the most cutting-edge approaches in helping individuals to get, and to remain, sober. As a result of their unique, innovative approaches to addiction treatment, Mountainside has become the model for the addiction treatment field.

The program, along with its professional addiction treatment team, have earned national recognition and resulted in Mountainside being invited to Washington by the White House to meet with the then White House Drug Czar, John P. Walters, for an in-depth meeting on what makes its program so successful. These accolades did not go unnoticed within the addiction treatment field and resulted in the adoption by many throughout the country of a more holistic approach to drug addiction treatment.

If you or someone you love is addicted to drugs or alcohol, or if you have any questions, please contact Mountainside Drug Rehab and Alcohol Treatment Center for a confidential inquiry at 800-762-5433

Via EPR Network
More Healthcare press releases

The Hearing Company Reveal Handy Tips for Hearing Aid Users to Stay Active and Play Sports

As we look back upon a fantastic year for British sport, the UK’s leading provider of modern hearing aids has some great ideas about participating in sport, despite any hearing difficulty.

When the success of the London 2012 Olympic Games was only added to by the Paralympic games, an important message was sent out which made clear that just about anybody could take part in fun and exciting competitive sport and all would benefit from doing so; even those with hearing difficulties.

The modern hearing aid allows the hearing impaired to lead as normal a life as possible, and do many of the things that they might have done previously. But wearing hearing aids and playing various sports can be extremely challenging, whether those sports are played individually, or as part of a team.

Communication is vital in team sport, but that communication needn’t purely be verbal. If you are keen to remove your hearing aid during the game, it is important to speak to your coach and your teammates and suggest the best way for them to communicate with you during practice and match play. When the coach is dishing out important words of wisdom, make sure you have a clear line of sight to the information, or suggest an alternative method of getting the information across, such as a whiteboard.

As small electronic devices, a number of hearing aids can be sensitive to excessive sweat. A simple headband or sweatband will prevent any moisture from affecting the hearing aid, and can even help to keep the device in place.

A number of waterproof digital hearing aids are available, and these devices, won’t just help with a little sweat, but can also be worn whilst swimming. These devices are more expensive to purchase and are only recommended to regular swimmers.

For more information about the different types of hearing aid available and the ways to book a hearing test with The Hearing Company, visit the official website today.

Via EPR Network
More Healthcare press releases